An observational study in Undifferentiated Shock, sponsored by Beth Israel Deaconess Medical Center. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-06-17.
Sponsored by Beth Israel Deaconess Medical Center · Observational
The Shock Tool study is designed to improve the clinical evaluation for differentiating shock in the emergency department. The goal of this study is to evaluate and improve the accuracy of physicians differentiating causes of shock.
Specific Aim #1: To study the epidemiology of shock in the emergency department Hypothesis 1: We will better understand shock states if we determine shock etiology among patients presenting to the emergency department in a carefully conducted observational prospective study.
Specific Aim #2: To determine the accuracy of physician diagnosis for the underlying etiology of shock.
Hypothesis 2: Physician assessment of the underlying cause of shock is challenging and often inaccurate in the early stages of care in the emergency department.
Specific Aim #3: To optimize the evidence-based approach to assist in the diagnosis of shock etiology from elements readily available when a patient demonstrates shock physiology in the Emergency Department.
Hypothesis 3: An evidenced-based, standardized approach to clinical decision making integrating elements of the history, physical exam, and early testing will improve a physician's ability to accurately differentiate etiologies of shock.
916 studies on the registry are indexed under Shock; 176 are open to participants now.
This study's enrollment of 2,500 is above the median of 91 across 346 observational studies indexed under Shock.
Browse Shock studies →Beth Israel Deaconess Medical Center is the lead sponsor of 560 studies on the registry; 80 are open to participants now.
Of its 75 completed or terminated interventional studies of FDA-regulated products, 61 (81%) have results posted.
Counted across the registry records on this site, refreshed daily.
Emergency Department patients
Exclusion Criteria:
Patients found to have persistent hypotension after resuscitation or vasopressor requirement
Patients with markedly abnormal vital signs (Heart Rate (HR)\>130, Respiratory Rate (RR)\>24, Shock Index \>1, Lactate \> 4.0mmol/L, or Systolic Blood Pressure (SBP) \<90mm/hg) without shock, as defined previously.
Etiology of Shock
Each patient determined to have shock in the emergency department is given a single diagnosis by a reviewing physician after the hospital course is completed.
Time frame: Retrospectively, 1 month after enrollment
In hospital mortality
Death by any cause during hospitalization
Time frame: This measure will be assessed at the time of physician review after discharge from hospital, on average 2 months after initial ED visit.
Deterioration
A composite outcome met if any of the following are present during hospitalization: acute renal failure (creatinine 2x baseline or new initiation of dialysis), non-elective intubation, vasopressor requirement, or mortality.
Time frame: This measure will be assessed at the time of physician review after discharge from hospital, on average 2 months after initial ED visit.
No study locations are listed for this record.
This study is completed, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beth Israel Deaconess Medical Center